| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 61.623 | 70.941 | 105.440 | 117.329 | 170.738 | 313.723 | 613.742 | 685.392 | 554.634 | 350.164 |
| Total Income - EUR | 61.624 | 70.942 | 105.442 | 117.330 | 191.940 | 327.909 | 617.489 | 729.149 | 555.658 | 353.096 |
| Total Expenses - EUR | 55.957 | 44.504 | 54.599 | 55.469 | 98.184 | 245.577 | 340.600 | 319.378 | 265.680 | 264.553 |
| Gross Profit/Loss - EUR | 5.667 | 26.438 | 50.843 | 61.861 | 93.756 | 82.332 | 276.889 | 409.770 | 289.978 | 88.544 |
| Net Profit/Loss - EUR | 3.818 | 25.418 | 47.131 | 60.898 | 92.045 | 79.775 | 270.997 | 402.488 | 278.560 | 74.422 |
| Employees | 4 | 4 | 4 | 4 | 14 | 12 | 16 | 14 | 7 | 8 |
Check the financial reports for the company - Friedl Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 279.847 | 268.832 | 257.196 | 246.369 | 307.559 | 345.674 | 353.808 | 299.766 | 310.489 | 264.857 |
| Current Assets | 20.939 | 19.423 | 11.117 | 35.152 | 74.010 | 97.801 | 156.909 | 259.955 | 167.444 | 139.217 |
| Inventories | 0 | 0 | 481 | 0 | 1.046 | 1.176 | 15.115 | 0 | 0 | 0 |
| Receivables | 14.061 | 6.394 | 8.349 | 3.946 | 18.756 | 36.685 | 77.729 | 208.151 | 158.836 | 134.564 |
| Cash | 6.879 | 13.029 | 2.286 | 31.206 | 54.208 | 59.939 | 64.065 | 51.804 | 8.608 | 4.653 |
| Shareholders Funds | 230.895 | 218.330 | 161.152 | 219.093 | 285.822 | 360.180 | 271.340 | 404.068 | 294.218 | 272.787 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 43 | 42 | 43 | 42 | 42 |
| Debts | 69.892 | 69.925 | 107.160 | 62.428 | 95.747 | 83.295 | 239.377 | 155.653 | 183.923 | 131.984 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Friedl Med Srl